APA (7th ed.) Citation

Y, L., H, M., X, X., Y, D., L, L., J, W., & W, Z. (2025). Deletion of ENO1 sensitizes pancreatic cancer cells to gemcitabine via MYC/RRM1-mediated glycolysis. Scientific reports, 15(1), 9941. https://doi.org/10.1038/s41598-025-94319-0

Chicago Style (17th ed.) Citation

Y, Lu, Ma H, Xiong X, Du Y, Liu L, Wang J, and Zhao W. "Deletion of ENO1 Sensitizes Pancreatic Cancer Cells to Gemcitabine via MYC/RRM1-mediated Glycolysis." Scientific Reports 15, no. 1 (2025): 9941. https://doi.org/10.1038/s41598-025-94319-0.

MLA (9th ed.) Citation

Y, Lu, et al. "Deletion of ENO1 Sensitizes Pancreatic Cancer Cells to Gemcitabine via MYC/RRM1-mediated Glycolysis." Scientific Reports, vol. 15, no. 1, 2025, p. 9941, https://doi.org/10.1038/s41598-025-94319-0.